379 related articles for article (PubMed ID: 32414074)
1. Past, Present and Future of Epigenetics in Adrenocortical Carcinoma.
Ettaieb M; Kerkhofs T; van Engeland M; Haak H
Cancers (Basel); 2020 May; 12(5):. PubMed ID: 32414074
[TBL] [Abstract][Full Text] [Related]
2. Adrenocortical carcinoma: current state of the art, ongoing controversies, and future directions in diagnosis and treatment.
Shariq OA; McKenzie TJ
Ther Adv Chronic Dis; 2021; 12():20406223211033103. PubMed ID: 34349894
[TBL] [Abstract][Full Text] [Related]
3. European Society of Endocrinology Clinical Practice Guidelines on the management of adrenocortical carcinoma in adults, in collaboration with the European Network for the Study of Adrenal Tumors.
Fassnacht M; Dekkers OM; Else T; Baudin E; Berruti A; de Krijger R; Haak HR; Mihai R; Assie G; Terzolo M
Eur J Endocrinol; 2018 Oct; 179(4):G1-G46. PubMed ID: 30299884
[TBL] [Abstract][Full Text] [Related]
4. An Interesting Case of Hepatic Adrenocortical Carcinoma.
Permana H; Darmawan G; Ritonga E; Kusumawati M; Miftahurachman M; Soetedjo NN
Acta Med Indones; 2018 Jul; 50(3):257-259. PubMed ID: 30333277
[TBL] [Abstract][Full Text] [Related]
5. Mitotane treatment for adrenocortical carcinoma: an overview.
De Francia S; Ardito A; Daffara F; Zaggia B; Germano A; Berruti A; Di Carlo F
Minerva Endocrinol; 2012 Mar; 37(1):9-23. PubMed ID: 22382612
[TBL] [Abstract][Full Text] [Related]
6. Clinical review: Adrenocortical carcinoma: clinical update.
Allolio B; Fassnacht M
J Clin Endocrinol Metab; 2006 Jun; 91(6):2027-37. PubMed ID: 16551738
[TBL] [Abstract][Full Text] [Related]
7. Surgical management of adrenocortical carcinoma.
Ranvier GG; Inabnet WB
Endocrinol Metab Clin North Am; 2015 Jun; 44(2):435-52. PubMed ID: 26038210
[TBL] [Abstract][Full Text] [Related]
8. microRNA-431 as a Chemosensitizer and Potentiator of Drug Activity in Adrenocortical Carcinoma.
Kwok GTY; Zhao JT; Glover AR; Gill AJ; Clifton-Bligh R; Robinson BG; Ip JCY; Sidhu SB
Oncologist; 2019 Jun; 24(6):e241-e250. PubMed ID: 30918109
[TBL] [Abstract][Full Text] [Related]
9. Epigenetic dysregulation in adrenocortical carcinoma, a systematic review of the literature.
Jonker PKC; Meyer VM; Kruijff S
Mol Cell Endocrinol; 2018 Jul; 469():77-84. PubMed ID: 28830787
[TBL] [Abstract][Full Text] [Related]
10. Future directions in the diagnosis and medical treatment of adrenocortical carcinoma.
Creemers SG; Hofland LJ; Korpershoek E; Franssen GJ; van Kemenade FJ; de Herder WW; Feelders RA
Endocr Relat Cancer; 2016 Jan; 23(1):R43-69. PubMed ID: 26475053
[TBL] [Abstract][Full Text] [Related]
11. Contemporary management of adrenocortical carcinoma.
Zini L; Porpiglia F; Fassnacht M
Eur Urol; 2011 Nov; 60(5):1055-65. PubMed ID: 21831516
[TBL] [Abstract][Full Text] [Related]
12. Pathobiology and genetics of adrenocortical carcinoma.
Pittaway JFH; Guasti L
J Mol Endocrinol; 2019 Feb; 62(2):R105-R119. PubMed ID: 30072419
[TBL] [Abstract][Full Text] [Related]
13. Current and emerging therapies for advanced adrenocortical carcinoma.
Oncologist; ; . PubMed ID: 21212436
[TBL] [Abstract][Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]